Tags

Type your tag names separated by a space and hit enter

The new European League Against Rheumatism/American College of Rheumatology diagnostic criteria for rheumatoid arthritis: how are they performing?
Curr Opin Rheumatol. 2013 May; 25(3):354-9.CO

Abstract

PURPOSE OF REVIEW

This era of early aggressive treatment of rheumatoid arthritis (RA) calls for criteria that allow timely classification of patients at risk of persistent erosive disease. We review how the new American College of Rheumatology (ACR)/European League Against Rheumatism (EULAR) classification criteria meet up to this challenge.

RECENT FINDINGS

The new 2010 ACR/EULAR classification criteria for RA were developed using initiation of methotrexate as anchor in a population with undifferentiated arthritis. Many studies from different countries have now been published that have addressed the performances of these new criteria.

SUMMARY

The goal of earlier classification of RA seems to be met with the new criteria, but exclusion of other diagnoses is essential. Increased sensitivity comes at the price of loss of specificity and indiscriminate use of these classification criteria as a diagnostic tool carries the risk of overtreatment.

Authors+Show Affiliations

Arthritis Center Twente, Medisch Spectrum Twente & University Twente, Enschede, The Netherlands.No affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

23492742

Citation

Vonkeman, Harald E., and Mart A F J. van de Laar. "The New European League Against Rheumatism/American College of Rheumatology Diagnostic Criteria for Rheumatoid Arthritis: How Are They Performing?" Current Opinion in Rheumatology, vol. 25, no. 3, 2013, pp. 354-9.
Vonkeman HE, van de Laar MA. The new European League Against Rheumatism/American College of Rheumatology diagnostic criteria for rheumatoid arthritis: how are they performing? Curr Opin Rheumatol. 2013;25(3):354-9.
Vonkeman, H. E., & van de Laar, M. A. (2013). The new European League Against Rheumatism/American College of Rheumatology diagnostic criteria for rheumatoid arthritis: how are they performing? Current Opinion in Rheumatology, 25(3), 354-9. https://doi.org/10.1097/BOR.0b013e32835f6928
Vonkeman HE, van de Laar MA. The New European League Against Rheumatism/American College of Rheumatology Diagnostic Criteria for Rheumatoid Arthritis: How Are They Performing. Curr Opin Rheumatol. 2013;25(3):354-9. PubMed PMID: 23492742.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The new European League Against Rheumatism/American College of Rheumatology diagnostic criteria for rheumatoid arthritis: how are they performing? AU - Vonkeman,Harald E, AU - van de Laar,Mart A F J, PY - 2013/3/16/entrez PY - 2013/3/16/pubmed PY - 2013/9/24/medline SP - 354 EP - 9 JF - Current opinion in rheumatology JO - Curr Opin Rheumatol VL - 25 IS - 3 N2 - PURPOSE OF REVIEW: This era of early aggressive treatment of rheumatoid arthritis (RA) calls for criteria that allow timely classification of patients at risk of persistent erosive disease. We review how the new American College of Rheumatology (ACR)/European League Against Rheumatism (EULAR) classification criteria meet up to this challenge. RECENT FINDINGS: The new 2010 ACR/EULAR classification criteria for RA were developed using initiation of methotrexate as anchor in a population with undifferentiated arthritis. Many studies from different countries have now been published that have addressed the performances of these new criteria. SUMMARY: The goal of earlier classification of RA seems to be met with the new criteria, but exclusion of other diagnoses is essential. Increased sensitivity comes at the price of loss of specificity and indiscriminate use of these classification criteria as a diagnostic tool carries the risk of overtreatment. SN - 1531-6963 UR - https://www.unboundmedicine.com/medline/citation/23492742/The_new_European_League_Against_Rheumatism/American_College_of_Rheumatology_diagnostic_criteria_for_rheumatoid_arthritis:_how_are_they_performing DB - PRIME DP - Unbound Medicine ER -